These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Recommendations on the therapy of bronchial carcinoma]. Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350 [No Abstract] [Full Text] [Related]
9. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma]. Ukena D; Hellwig D; Palm I; Rentz K; Leutz M; Hellwig AP; Kirsch CM; Sybrecht GW Pneumologie; 2000 Feb; 54(2):49-53. PubMed ID: 10731756 [TBL] [Abstract][Full Text] [Related]
10. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions? Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207 [TBL] [Abstract][Full Text] [Related]
11. Imaging strategies in the staging of lung cancer. Webb WR; Golden JA Clin Chest Med; 1991 Mar; 12(1):133-50. PubMed ID: 2009741 [TBL] [Abstract][Full Text] [Related]
12. [Clinical staging of bronchial carcinoma]. Russi EW Schweiz Rundsch Med Prax; 1989 Feb; 78(7):145-8. PubMed ID: 2538906 [TBL] [Abstract][Full Text] [Related]
13. Intrathoracic lymph node evaluation by CT and MRI with histopathologic correlation in non-small cell bronchogenic carcinoma. Georgian D; Rice TW; Mehta AC; Wiedemann HP; Stoller JK; O'Donovan PB Clin Imaging; 1990 Mar; 14(1):35-40. PubMed ID: 2157544 [TBL] [Abstract][Full Text] [Related]
14. [Value of computerized tomography for the staging of bronchial cancer]. Rotte KH; Kriedemann E; Hieckel GH; Engelmann C Z Erkr Atmungsorgane; 1984; 163(2):153-61. PubMed ID: 6095545 [TBL] [Abstract][Full Text] [Related]
15. Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation. Gross BH; Brown RK; Kalemkerian GP Lung Cancer; 2011 Jul; 73(1):59-62. PubMed ID: 21094559 [TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
17. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer. Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929 [TBL] [Abstract][Full Text] [Related]
18. Primary lung cancer invading the chest wall. McCaughan BC Chest Surg Clin N Am; 1994 Feb; 4(1):17-28. PubMed ID: 8055279 [TBL] [Abstract][Full Text] [Related]
19. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA. Crisci R; Di Cesare E; Lupattelli L; Coloni GF Eur J Cardiothorac Surg; 1997 Feb; 11(2):214-7. PubMed ID: 9080145 [TBL] [Abstract][Full Text] [Related]
20. Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET). Schmid RA; Hautmann H; Poellinger B; Kellner W; Moisseev A; Brinkbaeumer K; Weiss M; Hahn K; Dresel S Nucl Med Commun; 2003 Jan; 24(1):37-45. PubMed ID: 12501018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]